Browse Pet Safety Reports
15,441 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 15,441 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 15,441 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Feb 19, 2024 | Dog | Retriever - Golden | Bedinvetmab | Lethargy (see also Central nervous system depression in Neurological); Ataxia... | Ongoing |
| Feb 19, 2024 | Dog | Shepherd Dog - German, Retr... | Carprofen | Hind limb ataxia; Hind limb paresis; Limb weakness | Outcome Unknown |
| Feb 19, 2024 | Dog | Shepherd Dog - German | Moxidectin | Anaphylaxis; Bloody diarrhoea; Pale mucous membrane; Muscle weakness NOS; Lim... | Recovered/Normal |
| Feb 19, 2024 | Cat | Domestic Mediumhair | Cefovecin | Inappetence; Weakness; Inappropriate defecation; Inappropriate urination; Non... | Ongoing |
| Feb 19, 2024 | Dog | Maltese, Poodle (unspecified) | Bedinvetmab | Anaphylactic shock; Hypotension; Pale mucous membrane; Generalised weakness; ... | Ongoing |
| Feb 19, 2024 | Dog | Greyhound | Firocoxib | Lack of efficacy - NOS; Limb weakness; Ataxia; Death by euthanasia | Euthanized |
| Feb 19, 2024 | Dog | Greyhound | Bedinvetmab | Lack of efficacy - NOS; Limb weakness; Ataxia; Death by euthanasia | Euthanized |
| Feb 19, 2024 | Cat | Cat (unknown) | Robenacoxib | Inappetence; Weakness; Inappropriate defecation; Inappropriate urination; Non... | Ongoing |
| Feb 19, 2024 | Dog | Cattle Dog - Australian (bl... | Bedinvetmab | Ataxia; Diarrhoea; Cognitive disorder NOS; Difficulty standing; Limb weakness... | Euthanized |
| Feb 19, 2024 | Dog | Retriever - Labrador | Bedinvetmab | Limb weakness; Decreased activity; Hyperreflexia; Proprioception deficit; Per... | Outcome Unknown |
| Feb 18, 2024 | Dog | Retriever - Labrador | Bedinvetmab | Cough; Limb weakness; Decreased appetite; Shivering; Death | Died |
| Feb 17, 2024 | Dog | Maltese, Poodle - Miniature | Enrofloxacin | Behavioural disorder NOS; Muscle shaking; Limb weakness; Ataxia | Outcome Unknown |
| Feb 17, 2024 | Dog | Crossbred Canine/dog, Terri... | Fluralaner 5.46% 1-Month Chew | Lack of efficacy (bacteria) - Anaplasma; Cachexia; Decreased appetite; Decrea... | Died |
| Feb 17, 2024 | Dog | Retriever - Labrador | Moxidectin | Haematemesis; Lethargy (see also Central nervous system depression in Neurolo... | Died |
| Feb 17, 2024 | Dog | Terrier - Bull - American Pit | Bedinvetmab | Partial lack of efficacy; Ataxia; Limb weakness; Musculoskeletal disorder NOS | Outcome Unknown |
| Feb 16, 2024 | Dog | Terrier - Jack Russell | Bedinvetmab | Dysuria; Lethargy (see also Central nervous system depression in Neurological... | Ongoing |
| Feb 16, 2024 | Dog | Retriever - Labrador | Bedinvetmab | Hind limb ataxia; Nystagmus; Disoriented state; Generalised weakness | Ongoing |
| Feb 16, 2024 | Dog | Setter - English | Bedinvetmab | Diarrhoea; Ataxia; Collapse NOS (see also Cardio-vascular and Neurological di... | Ongoing |
| Feb 16, 2024 | Dog | Mixed (Dog) | Bedinvetmab | Restlessness; Vomiting; Drooling; Generalised weakness | Recovered/Normal |
| Feb 16, 2024 | Dog | Shiba Inu, Chihuahua | Bedinvetmab | Walking difficulty; Staring; Limb weakness; Trembling; Twitching; Head tremor... | Ongoing |
| Feb 16, 2024 | Dog | Bulldog - English | Bedinvetmab | Lethargy (see also Central nervous system depression in Neurological); Urinar... | Died |
| Feb 15, 2024 | Dog | Retriever - Labrador, Sheph... | Cefovecin | Vestibular disorder NOS; Medication error NOS; Inappropriate urination; Inapp... | Died |
| Feb 15, 2024 | Dog | Boxer (German Boxer), Dog (... | Moxidectin | Anaphylaxis; Diarrhoea; Generalised weakness; Pale mucous membrane; Emesis (m... | Recovered/Normal |
| Feb 15, 2024 | Dog | Shepherd (unspecified), Dog... | Bedinvetmab | Emesis (multiple); Lethargy (see also Central nervous system depression in Ne... | Ongoing |
| Feb 15, 2024 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Not eating; Weight loss; Ketosis; Weakness; Dehydration; High pancreatic-spec... | Ongoing |
| Feb 14, 2024 | Dog | Crossbred Canine/dog | Fluralaner 5.46% 1-Month Chew | Emesis (multiple); Dehydration; Weakness; Elevated creatinine; Elevated blood... | Ongoing |
| Feb 14, 2024 | Dog | Retriever - Labrador | Bedinvetmab | Localised hair loss; Skin scab; Weakness; Hot spot (pyotraumatic dermatitis);... | Ongoing |
| Feb 13, 2024 | Dog | Shepherd Dog - Australian | Bedinvetmab | Neurological symptoms NOS; Limb weakness; Ataxia; Death; Anorexia; Partial la... | Died |
| Feb 13, 2024 | Dog | Spitz - German Pomeranian | Moxidectin | Shaking; Lethargy (see also Central nervous system depression in Neurological... | Euthanized |
| Feb 13, 2024 | Dog | Terrier - Yorkshire | Bedinvetmab | Wobbliness; Limb weakness | Ongoing |
| Feb 13, 2024 | Cat | European | Insulin Injectable Vial | Hypoglycaemia; Lethargy (see also Central nervous system depression in Neurol... | Recovered/Normal |
| Feb 13, 2024 | Dog | Crossbred Canine/dog | Maropitant Citrate | Anorexia; Muscle weakness NOS; Pain NOS; Unable to stand; Inappropriate urina... | Ongoing |
| Feb 13, 2024 | Dog | Crossbred Canine/dog, Terri... | Fluralaner 13.64% 12-Week Chew | Generalised weakness; Lethargy (see also Central nervous system depression in... | Ongoing |
| Feb 13, 2024 | Dog | Terrier - Bull, Dog (unknown) | Grapiprant | Weakness; Lethargy (see also Central nervous system depression in Neurologica... | Recovered/Normal |
| Feb 13, 2024 | Dog | Shepherd Dog - Australian, ... | Bedinvetmab | Anorexia; Urinary incontinence; Faecal incontinence; Unable to walk; Hypoalbu... | Euthanized |
| Feb 13, 2024 | Dog | Collie - Border, Basenji | Bedinvetmab | Limb weakness; Stumbling gait | Outcome Unknown |
| Feb 13, 2024 | Dog | Collie - Border, Basenji | Bedinvetmab | Lameness; Weakness; Stumbling gait | Outcome Unknown |
| Feb 13, 2024 | Dog | Terrier - Bull - American P... | Bedinvetmab | Knuckling; Limb weakness; Excessive thirst | Ongoing |
| Feb 12, 2024 | Dog | Shepherd Dog - German | Bedinvetmab | Death by euthanasia; Weakness; Knuckling; Unsteady gait; Reluctant to move; D... | Euthanized |
| Feb 12, 2024 | Dog | Shepherd Dog - Australian | Bedinvetmab | Lethargy (see also Central nervous system depression in Neurological); Dry mo... | Ongoing |
| Feb 12, 2024 | Cat | European | Insulin Injectable Vial | Hypoglycaemia; Lethargy (see also Central nervous system depression in Neurol... | Recovered/Normal |
| Feb 12, 2024 | Dog | Terrier - Bull - Staffordshire | Bedinvetmab | Hind limb ataxia; Limb weakness | Ongoing |
| Feb 12, 2024 | Dog | Retriever - Golden | Bedinvetmab | Spasm; Muscle weakness NOS | Ongoing |
| Feb 12, 2024 | Dog | Cattle Dog - Australian (bl... | Bedinvetmab | Lameness; Polyuria; Polydipsia; Hind limb paresis; Hind limb ataxia; Proprioc... | Ongoing |
| Feb 11, 2024 | Dog | Crossbred Canine/dog | Afoxolaner | Behavioural disorder NOS; Trembling; Glazed eye; Staring; Weakness | Recovered/Normal |
| Feb 11, 2024 | Dog | Retriever - Golden, Poodle ... | Bedinvetmab | Unresponsive to stimuli; Febrile; Injection site pain; Implant site swelling;... | Ongoing |
| Feb 11, 2024 | Dog | Shih Tzu | Trilostane | Dysorexia; Appetite disorder NOS; Limb weakness; Hind limb ataxia; Ear infect... | Outcome Unknown |
| Feb 11, 2024 | Dog | Retriever - Labrador | Bedinvetmab | Vomiting; Mucous stool; Decreased appetite; Hypoalbuminaemia; Elevated serum ... | Recovered/Normal |
| Feb 10, 2024 | Cat | Domestic Shorthair | Praziquantel; Emodepside | Ataxia; Limb weakness; Seizure NOS; Paresis; Hiding; Anxiety; Decreased appet... | Ongoing |
| Feb 10, 2024 | Cat | Cat (other) | Frunevetmab | Musculoskeletal disorder NOS; Lameness; Hind limb ataxia; Unable to walk; Mus... | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.